- Tytuł:
- Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting.
- Autorzy:
- Źródło:
- British journal of cancer [Br J Cancer] 2015 Sep 29; Vol. 113 (7), pp. 1027-34. Date of Electronic Publication: 2015 Sep 10.
- Typ publikacji:
- Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Angiogenesis Inhibitors/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols /*administration & dosage
Biomarkers, Tumor/*blood
Colorectal Neoplasms/*drug therapy
Interleukin-8/*blood
Receptors, Vascular Endothelial Growth Factor/*administration & dosage
Recombinant Fusion Proteins/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/adverse effects ;Antineoplastic Combined Chemotherapy Protocols /adverse effects ;Antineoplastic Combined Chemotherapy Protocols /therapeutic use ; Biomarkers, Tumor/genetics ; Colorectal Neoplasms/blood ; Colorectal Neoplasms/genetics ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/therapeutic use ; Humans ; Leucovorin/administration & dosage ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Mutation ; Neoplasm Metastasis ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/therapeutic use ; Polymorphism, Single Nucleotide ; Receptors, Vascular Endothelial Growth Factor/adverse effects ; Recombinant Fusion Proteins/adverse effects ; Survival Analysis ; Treatment Outcome ; Vascular Endothelial Growth Factor B/genetics - SCR Protocol:
- Folfox protocol
Czasopismo naukowe